rs16947

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000106.6(CYP2D6):​c.886C>T​(p.Arg296Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 1,610,098 control chromosomes in the GnomAD database, including 108,422 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/6 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R296H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.39 ( 13067 hom., cov: 32)
Exomes 𝑓: 0.34 ( 95355 hom. )

Consequence

CYP2D6
NM_000106.6 missense

Scores

6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.921

Publications

375 publications found
Variant links:
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008255243).
BP6
Variant 22-42127941-G-A is Benign according to our data. Variant chr22-42127941-G-A is described in ClinVar as Benign. ClinVar VariationId is 242771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.512 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2D6NM_000106.6 linkc.886C>T p.Arg296Cys missense_variant Exon 6 of 9 ENST00000645361.2 NP_000097.3 P10635-1C1ID52Q5Y7H2
CYP2D6NM_001025161.3 linkc.733C>T p.Arg245Cys missense_variant Exon 5 of 8 NP_001020332.2 P10635-2Q5Y7H2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2D6ENST00000645361.2 linkc.886C>T p.Arg296Cys missense_variant Exon 6 of 9 NM_000106.6 ENSP00000496150.1 P10635-1

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
58085
AN:
150702
Hom.:
13023
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.231
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.394
Gnomad EAS
AF:
0.149
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.389
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.335
Gnomad OTH
AF:
0.382
GnomAD4 exome
AF:
0.336
AC:
490905
AN:
1459282
Hom.:
95355
Cov.:
56
AF XY:
0.339
AC XY:
245894
AN XY:
725958
show subpopulations
African (AFR)
AF:
0.527
AC:
17534
AN:
33292
American (AMR)
AF:
0.285
AC:
12714
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.406
AC:
10603
AN:
26114
East Asian (EAS)
AF:
0.144
AC:
5703
AN:
39588
South Asian (SAS)
AF:
0.384
AC:
33071
AN:
86116
European-Finnish (FIN)
AF:
0.387
AC:
20656
AN:
53394
Middle Eastern (MID)
AF:
0.425
AC:
2448
AN:
5754
European-Non Finnish (NFE)
AF:
0.330
AC:
366827
AN:
1110108
Other (OTH)
AF:
0.354
AC:
21349
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
21834
43668
65501
87335
109169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11546
23092
34638
46184
57730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.386
AC:
58174
AN:
150816
Hom.:
13067
Cov.:
32
AF XY:
0.386
AC XY:
28466
AN XY:
73670
show subpopulations
African (AFR)
AF:
0.518
AC:
21104
AN:
40762
American (AMR)
AF:
0.344
AC:
5230
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
1366
AN:
3468
East Asian (EAS)
AF:
0.148
AC:
757
AN:
5114
South Asian (SAS)
AF:
0.382
AC:
1822
AN:
4774
European-Finnish (FIN)
AF:
0.389
AC:
4104
AN:
10540
Middle Eastern (MID)
AF:
0.510
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
0.335
AC:
22641
AN:
67648
Other (OTH)
AF:
0.378
AC:
792
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1573
3147
4720
6294
7867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.322
Hom.:
2728
Bravo
AF:
0.386

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
Apr 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_noAF
Benign
-0.92
CADD
Benign
15
DEOGEN2
Benign
0.017
T;T;T;T;.
LIST_S2
Benign
0.26
.;.;T;T;T
MetaRNN
Benign
0.0083
T;T;T;T;T
PhyloP100
-0.92
Sift4G
Benign
0.18
.;.;T;T;T
Vest4
0.17, 0.18, 0.19
gMVP
0.61

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16947; hg19: chr22-42523943; API